Literature DB >> 11012627

Antigen-specific T cell responses in human peripheral blood leucocyte (hu-PBL)-mouse chimera conditioned with radiation and an antibody directed against the mouse IL-2 receptor beta-chain.

T Cao1, G Leroux-Roels.   

Abstract

A weakness of the hu-PBL-SCID model for the study of human immune functions is the appearance of anergy and the consequent loss of T cell function. We demonstrate here that human T cells retain normal functions during the early stage of chimerism. At 1 and 2 weeks post-engraftment, T cells isolated from the peritoneal cavity of hu-PBL chimeras could be activated and proliferated upon stimulation with phytohaemagglutinin (PHA) or specific antigens to which the cell donor was known to be immune. T cells derived from hu-PBL-SCID and hu-PBL-NOD/LtSz-scid (NOD/SCID) mice not only proliferated but also produced interferon-gamma (IFN-gamma) and IL-5 following in vitro stimulation with tetanus toxoid (TT) or hepatitis B surface antigen (HBsAg). These antigen-specific T cells could only be demonstrated when cognate antigen was administered together with or immediately following the PBL transfer. Without an early rechallenge with antigen in vivo, no TT- or HBsAg-specific T cell responses could be elicited, showing the vulnerability and antigen-dependence of the T cell response. Vigorous anti-TT or anti-HBs responses could be observed in all chimeras. Administration of antigen together with the PBL graft enhanced the humoral anti-TT response in SCID and NOD/SCID mice but had little effect on the anti-HBs antibody response in NOD/SCID mice. These data confirm the observation that the B cell compartment in hu-PBL-SCID chimera is largely antigen-independent and extend this to SCID/NOD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012627      PMCID: PMC1905761          DOI: 10.1046/j.1365-2249.2000.01340.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  SCID-bg mice as xenograft recipients.

Authors:  S Shibata; T Asano; A Ogura; N Hashimoto; J Hayakawa; K Uetsuka; H Nakayama; K Doi
Journal:  Lab Anim       Date:  1997-04       Impact factor: 2.471

2.  Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.

Authors:  S W Christianson; D L Greiner; R A Hesselton; J H Leif; E J Wagar; I B Schweitzer; T V Rajan; B Gott; D C Roopenian; L D Shultz
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

3.  On the SCIDs?

Authors:  D E Mosier; R J Gulizia; S M Baird; D B Wilson
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

4.  Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo.

Authors:  W O Böcher; H Marcus; R Shakarchy; B Dekel; D Shouval; E Galun; Y Reisner
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

5.  Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice.

Authors:  K G Tournoy; S Depraetere; R A Pauwels; G G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

Review 6.  Adoptive transfer of human lymphoid cells to severely immunodeficient mice: models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS.

Authors:  D E Mosier
Journal:  Adv Immunol       Date:  1991       Impact factor: 3.543

7.  Murine IL-2 receptor beta chain blockade improves human leukocyte engraftment in SCID mice.

Authors:  K G Tournoy; S Depraetere; P Meuleman; G Leroux-Roels; R A Pauwels
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

8.  Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries.

Authors:  M A Duchosal; S A Eming; P Fischer; D Leturcq; C F Barbas; P J McConahey; R H Caothien; G B Thornton; F J Dixon; D R Burton
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

Review 9.  The SCID mouse mutant: definition, characterization, and potential uses.

Authors:  M J Bosma; A M Carroll
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

10.  Transfer of a functional human immune system to mice with severe combined immunodeficiency.

Authors:  D E Mosier; R J Gulizia; S M Baird; D B Wilson
Journal:  Nature       Date:  1988-09-15       Impact factor: 49.962

View more
  8 in total

1.  Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice.

Authors:  A G S van Halteren; M J Kardol; A Mulder; B O Roep
Journal:  Diabetologia       Date:  2004-12-24       Impact factor: 10.122

2.  Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins.

Authors:  Arnone Nithichanon; Louise J Gourlay; Gregory J Bancroft; Manabu Ato; Yoshimasa Takahashi; Ganjana Lertmemongkolchai
Journal:  Immunology       Date:  2017-02-09       Impact factor: 7.397

3.  Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγ(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease.

Authors:  L Covassin; J Laning; R Abdi; D L Langevin; N E Phillips; L D Shultz; M A Brehm
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

4.  In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model.

Authors:  T Cao; P Meuleman; I Desombere; M Sällberg; G Leroux-Roels
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice.

Authors:  Santhi Gorantla; Edward Makarov; Jennifer Finke-Dwyer; Catherine L Gebhart; William Domm; Stephen Dewhurst; Howard E Gendelman; Larisa Y Poluektova
Journal:  J Immunol       Date:  2010-05-21       Impact factor: 5.422

6.  Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.

Authors:  Bruno Nervi; Michael P Rettig; Julie K Ritchey; Hanlin L Wang; Gerhard Bauer; Jon Walker; Mark L Bonyhadi; Ronald J Berenson; Julie L Prior; David Piwnica-Worms; Jan A Nolta; John F DiPersio
Journal:  Exp Hematol       Date:  2007-08-30       Impact factor: 3.084

7.  In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine.

Authors:  Wang Junwei; Zhan Xiumin; Ye Jing; Yang Shoujing; Li Zengshan
Journal:  Cancer Cell Int       Date:  2016-06-17       Impact factor: 5.722

8.  Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex.

Authors:  M A King; L Covassin; M A Brehm; W Racki; T Pearson; J Leif; J Laning; W Fodor; O Foreman; L Burzenski; T H Chase; B Gott; A A Rossini; R Bortell; L D Shultz; D L Greiner
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.